NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Argá Medtech

Argá Medtech

Private
EpalingesHealthcare & Life Scienceshttps://argamedtech.com/

Last Round

Series B

Feb 27, 2024

Total Funding Raised

$68.62M

Company Overview

Argá Medtech is a medical technology company that develops a proprietary coherent sine-burst electroporation system for treating cardiac arrhythmias.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

pulsed field ablationPFAcardiac ablationatrial fibrillationAFib treatmentcardiac arrhythmiaelectrophysiologyablation cathetermedical deviceelectroporationminimally invasivecardiology hardwarecardiac rhythm managementEP lab equipment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Argá Medtech Comparables

Compare Argá Medtech with similar companies based on industry and business-model similarity.

Argá Medtech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Field Medical
90%
Kardium
84%
Cortex, Inc.
82%

Argá Medtech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BFeb 27, 2024

Key People

Founding team and executive leadership

Randy Werneth

Chief Technology Officer

Executive Team

Argá Medtech Investors

Notable investors and investment history

Argá Medtech investors
InvestorRounds
Advent Life SciencesSeries B, Series A
Gilde HealthcareSeries B
Earlybird Venture CapitalSeries A, Series B
High-Tech GründerfondsSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 18, 2025

    Developing a Coherent Sine-Burst Electroporation system for cardiac arrhythmias.

  • Feb 27, 2024

    $59M round led by Advent Life Sciences and Earlybird Venture Capital.

Argá Medtech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Argá Medtech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Argá Medtech's valuation, stock price, and market status.

Firmographic Details

HeadquartersEpalinges
Employee Range39
Year Founded2020
Last FundingFeb 27, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.